LiveHire Ltd.
Robust growth in ARR and ARRPC: LiveHire Ltd. (ASX: LVH) stated in its recent release that it has secured a latest enterprise agreement with Korn Ferry RPO (Recruitment process & outsourcing) firm. The contract involves recruitment for one of the prominent real estate groups. This agreement would lead to a significant rise in the Annualised Recurring Revenue (ARR) of the firm.
For the Quarter ended 30 September 2018, LVH witnessed an ARR growth of 22% on quarter on quarter basis. This growth in ARR was on account of the success in the winning of 10 contracts. The average recurring revenue per client (ARRPC) grew significantly and came in at $27,885. This was on the back of the continued trend of winning larger clients.
.png)
Group Revenue and ARRPC (Source: Company Reports)
Meanwhile, the stock price has fallen by a substantial 27.34% over the past six months as on 3rd December 2018. This fall has provided a great accumulation opportunity for the long-term investors. The group has lower solvency issues Hence, considering the phenomenal growth in the key operational metrics such as ARR and attractiveness in terms of value, we give a “Speculative Buy” recommendation on the stock at the current market price of $0.50.
TheCitadel Group Ltd.
Robust Organic Growth: The Citadel Group Ltd. (ASX: CGL) stated in its recent release that it has acquired the government business of Gruden Pty Ltd. which is a government SaaS (Software as a service) platform from IncentiaPay for a sum of $1.65 million. This acquisition would further strengthen the competence and capabilities in the significant government sectors. Moreover, the company’s organic growth seems to be on track, which is evident from the fact that the firm has bagged contracts for CHARM, Citadel -IX and technology solutions. Apart from these, the firm has appointed Charles Pittar as the GM for its International operations, with the object of expanding internationally with more vigour.
.png)
CGL’s Key Financial Metrics (Source: Company Reports)
On the Financial metrics front, the company registered a robust ROE performance of 20.5%, which substantially outperformed the Industry median. Meanwhile, the stock price has risen by a substantial 28.89% over the past six months as on 3rd December 2018. Hence considering the aggressive organic growth that the company is pursuing and better than Industry ROE, we maintain our “Hold” recommendation on the stock at the current market price of $8.30.
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.
Past performance is not a reliable indicator of future performance.